Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Candel Therapeutics (CADL) Shares Issued: 2020-2022

Historic Shares Issued for Candel Therapeutics (CADL) over the last 2 years, with Dec 2022 value amounting to $36,000.

  • Candel Therapeutics' Shares Issued was N/A to $36,000 in Q4 2022 from the same period last year, while for Dec 2022 it was $71.0 million, marking a year-over-year change of. This contributed to the annual value of $1.7 million for FY2024, which is N/A change from last year.
  • As of Q4 2022, Candel Therapeutics' Shares Issued stood at $36,000, which was up 63.64% from $22,000 recorded in Q2 2022.
  • Over the past 5 years, Candel Therapeutics' Shares Issued peaked at $70.9 million during Q3 2021, and registered a low of $6,000 during Q1 2022.
  • For the 3-year period, Candel Therapeutics' Shares Issued averaged around $10.2 million, with its median value being $36,000 (2022).
  • Data for Candel Therapeutics' Shares Issued shows a maximum YoY slumped of 93.39% (in 2022) over the last 5 years.
  • Candel Therapeutics' Shares Issued (Quarterly) stood at $29,000 in 2020, then reached $70.9 million in 2021, then slumped by 93.39% to $36,000 in 2022.
  • Its last three reported values are $36,000 in Q4 2022, $22,000 for Q2 2022, and $6,000 during Q1 2022.